I’ve reported several times (see here) on Israeli life sciences company BioView and its innovative cancer detection technology.  BioView has just signed an agreement with Shenzhen China’s Livzon to distribute BioView’s imaging systems in China, Hong Kong, Macau, and Taiwan. … Continue reading →

An interview on ILTV Daily with Dr Alan Schwebel, President and CEO of Israel’s BioView, which I reported on previously (see here). Dr Schwebel describes Bioview’s scanning system for early detection of cancer cells and identification of the most appropriate … Continue reading →

The US FDA has approved the Duet scanning system, developed by Israeli biotech BioView, for the detection of mutations in lung cancer. http://www.globes.co.il/en/article-fda-approves-bioview-lung-cancer-scanning-system-1000938356 https://www.youtube.com/watch?v=QwlmGH8pTAw

Israeli biotech BioView’s cancer scanning systems will be integrated with French company ScreenCell’s technology to isolate rare tumour cells. The combined solution will improve diagnosis and speed up medical decisions about the best treatment options. http://www.globes.co.il/serveen/globes/docview.asp?did=1000764005&fid=1725

Israeli biotech BioView Ltd has announced that it has signed a cooperation agreement with OncoMDx of California, to develop a non-invasive diagnostic test for the early detection of non-small cell lung cancer (NSCLC). NSCLC accounts for 85% of all lung … Continue reading →